Skip to main content
. 2022 Dec 30;12(1):70. doi: 10.3390/antibiotics12010070

Table 2.

Prevalence of the main antimicrobial classes.

Antibiotics N (%)
ANTIBACTERIALS FOR SYSTEMIC USE (J01) 1163 (97.6)
Tetracyclines (J01A) 4 (0.3)
Amphenicols (J01B) 0 (0)
Penicillins (J01C) 147 (12.3)
Cephalosporins and carbapenems (J01D) 518 (43.5)
Sulfonamides and trimethoprim (J01E) 2 (0.2)
Macrolides and lincosamides (J01F) 54 (4.5)
Aminoglycosides (J01G) 129 (10.8)
Quinolones (J01M) 59 (5.0)
Other antibacterial (J01X) 247 (20.7)
ANTIMYCOTICS FOR SYSTEMIC USE (J02) 0 (0)
ANTIMYCOBACTERIALS FOR SYSTEMIC USE (J04) 11 (0.9)
ANTIVIRALS FOR SYSTEMIC USE (J05) 13 (1.1)
ANTIPROTOZOALS (P01) 0 (0)